These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25720313)

  • 1. Cash, choice, antipsychotic medication and the mental health nurse.
    Gray R
    J Psychiatr Ment Health Nurs; 2015 Mar; 22(2):149-53. PubMed ID: 25720313
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the community mental health nurse in the administration of depot neuroleptic medication: 'not just the needle nurse!'.
    Muir-Cochrane EC
    Int J Nurs Pract; 1998 Dec; 4(4):254-60. PubMed ID: 10095520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on: Hegedüs A. and Kozel B. (2014). Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review. International Journal of Mental Health Nursing, doi: 10.1111/inm.12089.
    Gray R; Bressington D; von Bormann S; Schulz M; Brown E; Anderson K; Jones M
    Int J Ment Health Nurs; 2015 Aug; 24(4):370-2. PubMed ID: 26122907
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing patients with antipsychotic drug-induced hyperprolactinaemia.
    Jones A; Jones M
    Nurs Stand; 2008 Oct 15-21; 23(6):48-55; quiz 56. PubMed ID: 18988568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delaying time to relapse in schizophrenia. The role of long-acting injectable antipsychotics.
    Muller R
    Manag Care; 2014 Apr; 23(4 Suppl 1):2-3. PubMed ID: 25029779
    [No Abstract]   [Full Text] [Related]  

  • 6. Managed care considerations. Optimal pharmacotherapy of schizophrenia.
    Muller R
    Manag Care; 2014 Apr; 23(4 Suppl 1):4. PubMed ID: 25029780
    [No Abstract]   [Full Text] [Related]  

  • 7. Organizational fidelity to a medication management evidence-based practice in the treatment of schizophrenia.
    El-Mallakh P; Howard PB; Rayens MK; Roque AP; Adkins S
    J Psychosoc Nurs Ment Health Serv; 2013 Nov; 51(11):35-44. PubMed ID: 23944183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication.
    Jones M; Jones A
    J Psychiatr Ment Health Nurs; 2007 Jun; 14(4):418-23. PubMed ID: 17517033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).
    Brugnoli R; Rapinesi C; Kotzalidis GD; Marcellusi A; Mennini FS; De Filippis S; Carrus D; Ballerini A; Francomano A; Ducci G; Del Casale A; Girardi P
    Riv Psichiatr; 2016; 51(2):47-59. PubMed ID: 27183509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining levels of antipsychotic adherence to better understand nonadherence.
    Remington G; Teo C; Mann S; Hahn M; Foussias G; Agid O
    J Clin Psychopharmacol; 2013 Apr; 33(2):261-3. PubMed ID: 23422390
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenia care: failings and recommendations.
    Tingle J
    Br J Nurs; 2012 Dec 13-2013 Jan 9; 21(22):1350-1. PubMed ID: 23249804
    [No Abstract]   [Full Text] [Related]  

  • 16. Enforced medication and virtue-ethics.
    Armstrong A
    J Psychiatr Ment Health Nurs; 1999 Aug; 6(4):329-34. PubMed ID: 10763670
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to Antipsychotic Therapy: Association With Hospitalization and Medicare Spending Among Part D Enrollees With Schizophrenia.
    Roberto P; Brandt N; Onukwugha E; Perfetto E; Powers C; Stuart B
    Psychiatr Serv; 2017 Nov; 68(11):1185-1188. PubMed ID: 28760097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH;
    Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis and medication: strategies for improving adherence.
    Coffey M
    Br J Nurs; 1999 Feb 25-Mar 10; 8(4):225-30. PubMed ID: 10347408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
    Kulkarni J; Reeve-Parker K
    Australas Psychiatry; 2015 Jun; 23(3):258-64. PubMed ID: 25783668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.